<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>28</o:Revision>
  <o:TotalTime>529</o:TotalTime>
  <o:Created>2006-04-24T08:42:00Z</o:Created>
  <o:LastSaved>2006-04-27T14:43:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>536</o:Words>
  <o:Characters>3059</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>25</o:Lines>
  <o:Paragraphs>6</o:Paragraphs>
  <o:CharactersWithSpaces>3756</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1035"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='mso-field-code:"HYPERLINK \0022http\:\/\/www\.ebi\.ac\.uk\/interpro\/index\.html\0022 \\o \0022To the InterPro database\0022"'><span
style='text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:139.5pt;
 height:45pt'>
 <v:imagedata src="./Page2_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=186 height=60
src="./Page2_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Tissue Factor<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>The Blood Coagulation Cascade<o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='text-align:justify;text-indent:36.0pt'>Damage to
blood vessel walls exposes Tissue Factor-containing cells from underlying cell
layers to the bloodstream.<span style="mso-spacerun: yes">  </span>Tissue
Factor (TF) is then able to bind in the presence of calcium to Factor VII
(FVII), which circulates at low levels in the bloodstream, the calcium forming
a bridge between TF and FVII.<span style="mso-spacerun: yes">  </span>This sets
off an extracellular cascade involving sequential serine protease
activations:<span style="mso-spacerun: yes">  </span>TF/FVII is activated by
auto-cleavage to TF/FVIIa, which along with FVIIIa (cofactor) converts FIX to
FIXa, which converts FX to FXa (although TF/FVIIa can also directly convert FX
to FXa), which along with FVa (cofactor) converts FII (prothrombin) to FIIa
(thrombin), which converts fibrinogen to fibrin, leading to fibrin deposition
and the activation of platelets to form blood clots (the activation of FXIII to
FXIIIa stabilises the fibrin clot by cross-linking it):</p>

<p class=MsoNormal style='text-align:justify'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 valign=top style='width:426.1pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><!--[if gte vml 1]><v:shape
   id="_x0000_i1026" type="#_x0000_t75" style='width:414.75pt;height:89.25pt'>
   <v:imagedata src="./Page2_files/image003.png" o:title="Blood_coagulation_cascade_6"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=553 height=119
  src="./Page2_files/image004.jpg" v:shapes="_x0000_i1026"><![endif]></p>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#F3F3F3;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><b>Blood Coagulation
  Cascade<o:p></o:p></b></p>
  </td>
 </tr>
</table>

<p class=MsoBodyText style='text-indent:36.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>Feedback Inhibition<o:p></o:p></span></h2>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Tissue
Factor Pathway Inhibitor (TFPI) is an anti-coagulation protein that acts as a
Kunitz-type serine protease inhibitor.<span style="mso-spacerun: yes"> 
</span>TFPI is a dual inhibitor, binding to the TF/FVIIa complex to prevent it
from acting on its FIX and FX substrates, and by directly inhibiting FXa as
well - in fact, the TFPI/FXa complex is a more effective inhibitor of TF/FVIIa
than TFPI alone, possibly by forming a large TFPI/FXa/TF/FVIIa complex.<span
style="mso-spacerun: yes">  </span>Therefore FXa exerts negative feedback on its
own production.<span style="mso-spacerun: yes">  </span>With the inhibition of
the TF/FVIIa complex, additional FIXa and FXa can only be produced through the
action of FXIa, which is generated from FXI by thrombin in the later part of
the cascade.<span style="mso-spacerun: yes">  </span>Therefore, the action of
TFPI is not absolute.<span style="mso-spacerun: yes">  </span>TFPI is thought
to be important in modulating TF-induced thrombogenesis, since inappropriate
thrombus formation in blood vessels can cause cardiovascular diseases such as
myocardial infarction, stroke, and pulmonary embolism, amongst others.</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 valign=top style='width:426.1pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><b><!--[if gte vml 1]><v:shape
   id="_x0000_i1027" type="#_x0000_t75" style='width:414.75pt;height:126.75pt'>
   <v:imagedata src="./Page2_files/image005.png" o:title="Coagulation_inhibition_4"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=553 height=169
  src="./Page2_files/image006.jpg" v:shapes="_x0000_i1027"><![endif]><o:p></o:p></b></p>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><b><o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#F3F3F3;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><b>Inhibition of
  the Tissue Factor Pathway<o:p></o:p></b></p>
  </td>
 </tr>
</table>

<p class=MsoBodyText style='text-indent:36.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2><span style='color:navy;font-style:normal'>A Link between Blood Coagulation
and Inflammation<o:p></o:p></span></h2>

<p class=MsoBodyText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Tissue
Factor also has an important role to play in inflammation, since the initiation
of the extracellular blood coagulation signalling pathway can trigger an intracellular
inflammation-signalling pathway.<span style="mso-spacerun: yes">  </span>The
activated coagulation factors FVIIa, FXa and FIIa (thrombin) are
pro-inflammatory, capable of inducing an inflammatory state via
protease-activated receptors (PAR) found on the surface of several cell types.<span
style="mso-spacerun: yes">  </span>The activation of PAR receptors can induce
the expression of a variety of inflammatory molecules, including tissue
necrosis factor, interleukins, adhesion molecules (MCP-1, ICAM-1, VCAM-1), and
growth factors (VEGF, PDGF, bFGF), amongst others.<span style="mso-spacerun:
yes">  </span>PARs are G-protein-coupled receptors (GPCRs), where PAR-1, 3 or 4
transmits FIIa signalling, PAR-1, 2 or 3 transmits FXa signalling, and PAR-2
transmits FVIIa signalling.<span style="mso-spacerun: yes">  </span>Fibrin is
also able to promote an inflammatory response.<span style="mso-spacerun: yes"> 
</span>In addition to PAR receptor activation, the phosphorylation of the
cytoplasmic domain of Tissue Factor can lead to intracellular signalling
events.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText style='text-indent:36.0pt'>Furthermore, inflammation can
promote coagulation through a feedback loop on TF expression: various
inflammatory signals, such as AP-1, Erg-1 and NF<span style='font-family:Symbol'>k</span>B,
can increase TF expression, enhancing its availability for FVII or FVIIa
binding. This creates a coagulation-inflammation cycle, where each pathway
promotes the other.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=568 valign=top style='width:426.1pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><b><!--[if gte vml 1]><v:shape
   id="_x0000_i1028" type="#_x0000_t75" style='width:415.5pt;height:163.5pt'>
   <v:imagedata src="./Page2_files/image007.png" o:title="Inflammatory_coagulation_cycle"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=554 height=218
  src="./Page2_files/image008.jpg" v:shapes="_x0000_i1028"><![endif]><o:p></o:p></b></p>
  <p class=MsoBodyText align=center style='text-align:center'><![if !supportEmptyParas]>&nbsp;<![endif]><b><o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width=568 valign=top style='width:426.1pt;background:#F3F3F3;padding:
  0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoBodyText align=center style='text-align:center'><b>Inflammation
  and Blood Coagulation Pathways<o:p></o:p></b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page3.htm">What InterPro Tells Us</a><o:p></o:p></span></h2>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page1.htm">Tissue Factor, Starting
the Coagulation Cascade</a><o:p></o:p></span></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
